Introduction
Heme is the prosthetic group of all hemoproteins such as hemoglobin, myoglobin, microsomal and mitochondrial cytochromes, catalase, peroxidases, nitric oxide synthase, prostaglandin synthase, and certain transcription factors. As such, heme plays a crucial role in fundamentally important physiological, pharmacological and toxicological reactions. In vitro native hemoglobin can be perfectly renatured from heme and apoglobin, at a rapid rate constant of 5 × 10 4 M −1 sec −1 [1] . Then why is heme degraded to iron, biliverdin IXα and carbon monoxide (CO) in vivo? There may be several reasons for this to occur. For example, as "free heme" is a lipophilic molecule, it intercalates in the membrane and lipid bilayers and organelles, such as mitochondria and nuclei, and destabilizes the cytoskeleton. It is highly toxic, particularly in kidney, liver, central nervous system and cardiac tissue [2] . Heme concentration greater than 1 µM can be toxic to almost all cells because it catalyzes the production of reactive oxygen species, most notably the hydroxyl radicals [3] . "Free heme" can also induce low-density lipoprotein (LDL) oxidation, which is extremely toxic to aortic endothelial cells [4, 5] . In order to cope with this problem, the body is equipped with various defense mechanisms against high "free heme" concentrations. Heme oxygenase is one of the major players in this defense mechanism, which catalyzes the degradation of "free heme" to iron, biliverdin IXα and CO.
Iron is released from heme when heme oxygenase catalyzes its degradation. This reaction is also crucial for the recycling of iron since only 1-3% of the daily iron requirement is obtained from dietary intake [6] . Iron release from heme induces the synthesis of ferritin, a storage system for iron. Ferritin is an acute-phase reactant that is regulated essentially by the same stimuli as heme oxygenase-1, including iron and heme, UV irradiation, and hypoxia / reoxygenation [7] , and serves to protect cells from oxidized stress [8] . Thus both these stress proteins are coordinately up-regulated during oxidative stress [9] . Heme oxygenase-1 up-regulation increases the availability of iron, which contributes to ferritin synthesis as the binding of iron and iron-regulatory proteins to iron-responsive elements in the ferritin gene increases ferritin synthesis [10] . Under conditions of oxidative stress, the role of liver ferritin may be complex, however, as its early degradation contributes to expand the intracellular free iron pool that, later on, activates multiple molecular mechanisms to reconstitute ferritin content, thus limiting the pro-oxidant challenge of iron [7] . Thus it can represent either a pro-or anti-oxidant depending on the time of events.
Bilirubin IXα is long-known as a toxic agent associated with kernicterus in newborn babies [11] . Itching observed with jaundice of various causes may also reflect bilepigment toxicity [12] . Recently, however, the protective effect of biliverdin IXα and bilirubin IXα, which is produced from the former by biliverdin reductase, has attracted much attention as important anti-oxidants [13, 14] . Although the protective effects of bile pigments in vitro and in vivo during heme degradation are of considerable interest, it remains to be established whether the protective effects can be demonstrated as a therapeutic modality without causing well-known toxic effects of these compounds in vivo.
The biomodulating effect of CO has also attracted much attention recently. For example, CO is a vasodilator [15, 16] , as is NO, and also serves as a messenger molecule, particularly in the neuronal tissue. Both NO and CO are involved in the formation of cGMP as gaseous activators [17] . While CO is a much poorer stimulator for soluble guanylate cyclase activity than NO, it has been implicated as an important physiological stimulator of soluble guanylate cyclase in neurotransmission and vasorelaxation. CO apparently stabilizes the enzyme's active configuration and is capable of stimulating soluble guanylate cyclase to a degree similar to NO [18] . However, there are also significant differences in their modes of action between the two diatomic gas molecules. For one, CO is not a radical species, while NO is. While NO formation is tightly regulated in an "on-off" manner, as NO immediately reacts with metal ions, reactive oxygen species, and sulfhydryl groups in the cell, CO formation by heme oxygenase-1 is not as tightly regulated as NO, and reflects more of the heme oxygenase-1 levels. CO reaction mechanism apparently involves a fivecoordinate intermediate, and is presumably responsible for 4-fold activation of guanyl cyclase by CO [17] . CO, rather than NO, also appears to act to control hepatic cGMP levels and sinusoidal resistance [19] . CO also suppresses apoptosis of endothelial cells. As such, the metabolites of heme by heme oxygenase reactions have additionally important functions, and are involved in various cellular defense mechanisms. Thus the breakdown of heme to smaller elements has its own significance in essential cellular metabolism.
Text

Disposal of Hemoglobin
Hemoglobin in red blood cells is the most abundant hemoprotein in the body, and is maintained by its constant synthesis and degradation. There is approximately 700 g of hemoglobin in a 70-kg man, and about 0.8% of it is degraded daily by catabolism and replenished by biosynthesis. Hemoglobin consists of four globin subunits, typically of two different types, and every subunit contains one heme molecule. Heme is composed of protoporphyrin IX and ferrous iron. "Free heme" is considered as a proteinunbound heme which is either newly synthesized but not yet combined with apohemoprotein, or free heme released from a hemoprotein but not yet destroyed by HO. Free heme is thought to be turning over very rapidly [20] , and will soon either bind with apohemoproteins [21] , or undergoes degradation by HO. Free heme is also thought to be in an equilibrium with tryptophan pyrrolase, a heme-dependent enzyme [22] (Fig. 1) .
After about 120 days in circulation, erythrocytes are engulfed by splenic macrophages. Then their components undergo extensive breakdown. Namely, globin is degraded to amino acids, while heme is degraded to one molecule each of iron, biliverdin IXα and CO. Under physiological conditions, globin is completely degraded into amino acids that are reutilized for protein synthesis, iron is sequestered into ferritin, and biliverdin IXα is converted to bilirubin IXα by biliverdin reductase, while CO is excreted into air. If however, excessive concentrations of hemoglobin exceeding the capacity of metabolic pathways are released into plasma, they contribute, as free globin [23] and / or free heme [24] , to the pathogenesis of toxic cellular injuries such as atherosclerosis [25] .
There are haptoglobin-dependent and haptoglobinindependent mechanisms for free hemoglobin removal in plasma. Hemoglobin released into plasma is immediately captured by haptoglobin, an acute phase protein, and is depleted from plasma during elevated hemolysis. At low hemoglobin concentrations, i.e., <8 nM, hemoglobin is completely bound to haptoglobin [26] , and haptoglobin forms a stable complex with hemoglobin, with the association constant of 10 −15 mol / l [27] (Fig. 2) . Haptoglobin, however, does not bind free heme, which is bound by hemopexin (Fig. 2) . The stable hemoglobin-haptoglobin complex is then removed from the bloodstream by mononuclear phagocyte system through the hemoglobin scavenging receptor, CD163, which is expressed on the surface of macrophages [28] (Fig. 2) . The extracellular region of CD163 consisting of nine scavenger receptor cysteine-rich domains also circulates in plasma as a soluble protein [29] . The receptor-ligand interaction of the hemoglobin-haptoglobin complex is Ca 2+ -dependent [29] . The haptoglobin-dependent hemoglobin scavenging by CD163 prevents toxic effects of hemoglobin in plasma in normal subjects. In haptoglobin deficiency, increased deposition of hemoglobin takes place in proximal tubules of the kidney, instead of the liver and the spleen as occurs in the wild-type animals, and contributes to the renal iron loading and cellular injury [30] . The binding of hemoglobin to haptoglobin also enhances its hepatocellular entry, clearance, and distribution [26] . Polymorphisms in haptoglobin may affect vascular complications in diabetes, probably due to functional differences in neutralizing the oxidative effects of globin-associated heme [31] .
Even after haptoglobin binding capacity is exhausted by Fig. 1 . Free heme. Free heme is a protein-unbound heme, which has either been recently synthesized but not yet incorporated into hemoprotein, or that which has been released from hemoprotein such as hemoglobin, myoglobin, or cytochrome P450, but not yet degraded by heme oxygenase (HO). The majority of free heme is utilized for new hemoprotein synthesis, but it also exerts various regulatory functions, including the repression of non-specific δ-aminolevulinate synthase (ALAS1) synthesis and the induction of HO-1. Free heme is also in equilibrium with tryptophan pyrrolase, a heme-dependent enzyme.
severe hemolysis, hemoglobin can continue to interact with CD163, and is internalized into an endosomal compartment by CD163 in the absence of haptoglobin [32] . Free hemoglobin then induces heme oxygenase-1 mRNA expression in CD163-positive cells, but not in CD163-negative cells [32] . Binding of hemoglobin-haptoglobin to CD163-positive cells also elicits IL-10 secretion and, in turn, contributes to the induction of heme oxygenase-1, both of which can be inhibited by anti-CD163 antibody [33] . Thus, both haptoglobin and CD163 play an important physiological role as an anti-oxidant, and also enhance the expression of heme oxygenase-1, the major cytoprotective response.
Heme Clearance from Circulation
Recent studies have shown that heme deficiency leads to cellular senescence and causes suppression of NMDA receptor subunits expression in primary cortical neurons [34] . Heme is thus an essential molecule for pharmacological and toxicological processes and for cellular aging. Free heme serves, however, as a double-edged sword in cell biology. Namely, while it is an essential element for forming hemoproteins and regulating gene expression such as globin and Bach1 at low or physiological concentrations, it can become highly toxic by mediating oxidative stress and inflammation at non-physiologically high concentrations. Hemopexin is a heme-binding plasma glycoprotein, which, after haptoglobin, forms the second line of defense against hemoglobin-mediated oxidative damage during intravascular hemolysis. Hemopexin binds heme at a ratio of 1 mol of heme per mol with high affinity (Kd<1 pM) [35] . Hemehemopexin complexes are delivered to hepatocytes by receptor-mediated endocytosis after which hemopexin is recycled to the circulation. Gene expression of heme oxygenase-1, transferrin, the transferrin receptor, and ferritin are all regulated by heme-hemopexin complex [36] . For the membrane receptor-mediated process of heme release from hemopexin, the generation of cuprous ion [36] is apparently required at the cell surface. This process is due to reduction followed by oxidation by a multi-copper oxidase [37] , which then results in the heme-hemopexin-mediated induction of the protective proteins, metallothionein-1 and heme oxygenase-1 [36] . There are several redox-sensitive transcription factors such as c-Jun, RelA/ NFκB and metallothionein-1 that are also activated by the hemopexin system [36] .
As discussed above, both haptoglobin and hemopexin exert an antioxidant effect by preventing free radical production. It is thus anticipated that their genetic deficiency would be detrimental against inflammation. This point was examined in haptoglobin-hemopexin double-null mice. While these animals displayed no obvious alteration in phenotype under basal conditions, nonlethal oxidative stress by free hemoglobin or free heme led to pronounced splenomegaly as well as liver inflammation and fibrosis [38] . Thus it is clear that haptoglobin and hemopexin together are essential for protection from splenomegaly and liver fibrosis resulting from the oxidative damage by free hemoglobin / free heme during intravascular hemolysis.
Recently, the low-density lipoprotein (LDL) receptorrelated protein (LRP / CD91), a multifunctional scavenger expressed in brain, placenta, liver, fibroblasts, adipocytes, and macrophage/ monocytes, has also been identified as the novel heme-hemopexin receptor [39] , thus linking heme metabolism to a known receptor with well-characterized endocytic properties and signaling functions [40] . LRP / CD91 is a transmembrane protein with numerous functions, including plasma protein scavenging, intracellular signaling, and neurotransmission [34] . Heme-hemopexin taken up by LRP / CD91 by monocytes induces heme oxygenase-1 [39] (Fig. 2) , and as such it could inhibit their inflammatory functions in phagocytic and anti-inflammatory ("alternatively activated") macrophages [41] .
Intracellular Heme Catabolism
After heme is removed from plasma and taken up by cells such as macrophages, or released intracellularly from hemoproteins in hepatocytes, it is degraded to smaller molecules in the cell by heme catabolism. This process is catalyzed by a sequence of three enzymatic reactions, involving NADPH-cytochrome P450 reductase, heme oxygenase, and biliverdin reductase. The initial step in this sequence is the formation of a ferric heme-heme oxygenase complex, which is then oxidized by a reducing equivalent provided by NADPH-cytochrome P450 reductase in the presence of NADPH (Fig. 3 ) [42] . It is therefore clear that heme oxygenase is quite unique in that it utilizes heme in a dual role, one as a substrate and the other as a prosthetic group. Heme oxygenase is the enzyme that catalyzes the regiospecific cleavage of the α-methene bridge of heme to produce iron, biliverdin IXα, and CO, and is the ratelimiting step in the entire sequence [43] . The activation of oxygen by heme oxygenase starts with the one-electron reduction of the heme-heme oxygenase complex, followed by the binding of dioxygen to form an oxyferrous complex (Fe 2+ -O2). Importantly, heme oxygenase can also form an equimolar complex with NADPH-cytochrome P450 reductase [44] , suggesting that the heme cleavage reaction by heme oxygenase may proceed in a very efficient manner within the binary complex located in the endoplasmic reticulum.
There are two catalytically active heme oxygenase isozymes, heme oxygenase-1 [45] and heme oxygenase-2 [46] , and the one that plays the major role in the catabolism of hemoglobin heme is the heme-inducible heme oxygenase-1. Biliverdin IXα is reduced to bilirubin IXα, the major bile pigment, by cytosolic biliverdin reductase. Enzyme kinetic analysis in vitro suggested that biliverdin reductase may also interact with the NADPH-cytochrome P450 reductase-heme oxygenase complex [44] . Thus, biliverdin IXα, formed by the NADPH-cytochrome P450 reductase-heme oxygenase complex might also be converted to bilirubin IXα without leaving the enzyme complex in the endoplasmic reticulum. Daily production of bilirubin IXα in a man amounts to ca. 400 mg, and about 75% of which are accounted for by the degradation of hemoglobin heme [47, 48] .
The Toxic Effects of Free Heme
As discussed above, the body needs to maintain "free heme" concentrations at an extremely low level. Then what might be the exact concentration of "free heme" in the body? A serum concentration of ~0.5 mM heme found in a baby boy with inherited heme oxygenase-1 deficiency was clearly abnormal and toxic, since it was associated with extensive hemolysis and a vast array of oxidative damages of organ, tissue and cellular injury, and ultimately with an early death of the boy [49] . Free heme catalyzes the oxidation, covalent cross-linking and aggregate formation of protein and its degradation to small peptides [2] . It also catalyzes the formation of cytotoxic lipid peroxide via lipid peroxidation, and displays genotoxic effects by damaging DNA through oxidative stress. As judged from the Km of the heme oxygenase-1 reaction, i.e., 1 µM, "free heme" concentration in normal cells must be much lower than 1 µM (Fig. 4) . If "free heme" concentration is assumed to be in a close vicinity of the concentration of "free iron", the HO-mediated product of heme, it should not be greater than 10 −9 M [50] . Some bacteria can utilize heme as a sole source of iron, suggesting that bacterial heme oxygenases are essential part of their pathway to mine iron from host heme [51] [52] [53] [54] [55] . However, it is quite difficult to determine such low "free heme" concentrations in the cell by conventional methods [56] . In a pulse chase experiment with 59 Fe-transferrin, the "free heme" pool in reticulocytes in Belgrade rats was shown to behave as an intermediate for hemoglobin biosynthesis, with a rapid half-life of a little over 2 hours [57] . With the exception of this animal model, no direct demonstration of "free heme" concentration is known. Indirect evidence suggests, however, that there is a cytosolic "free heme" pool, as judged by changes in the saturation of tryptophan pyrrolase with heme. For example, rat liver tryptophan pyrrolase heme is rapidly depleted at 30 min after administration of 2-allyl-2-isopropylacetamide, and this depletion is accompanied by an increase of ALAS Fig. 2 . Clearance of hemoglobin and heme from circulation. CD163 and LRP / CD91 represent two major pathways for uptake of extracellular hemoglobin and free heme in circulation. Both receptors are highly expressed in phagocytic macrophages, which are known to metabolize heme into iron, biliverdin IXα, and CO. In addition to macrophages, LRP / CD91 is also markedly expressed in several other tissues, including hepatocytes, neurons, and syncithiotrophhoblasts [165] .
activity [58] . The greatest confounding factor in "free heme" determination is the fact that "free heme" is in a rapid dynamic equilibrium between the protein-bound and the unbound state [20, 57] . Thus, even using column chromatography that can separate "free heme" from hemoproteins, results obtained may not necessarily reflect the exact concentration of "free heme" in cells.
The Regulatory Effects of Free Heme
The regulatory effects of free heme have been largely unrecognized in the past, in part due to the fact that its concentration is below the detection limit. Nonetheless, evidence suggests that "free heme" at such low concentrations must play an important regulatory role on various cellular events. For example, exogenously added hemin at 10 −7 M represses the synthesis of the non-specific δ-aminolevulinate synthase (ALAS1), and at 10 −6 M induces heme oxygenase-1 in cultured chick embryo liver cells [21] . Since significant amounts of heme were adhered to and remained at the cell membrane, these effects must be occurring even at much lower concentrations of heme than the added concentration to culture medium. Recently it was reported that the mammalian transcription factor Bach1, a repressor of heme oxygenase-1 gene activation [59] , binds with an equimolar amount of hemin [60] . Hemin at 1 µM almost completely inhibited the DNA-binding activity of Bach1 in vitro. Interestingly, even as low as 0.03 µM hemin caused a slight but reproducible inhibition of DNA-binding by Bach1-MafK hetero-oligomer. These findings suggest that the physiologically important concentration of "free heme" in the cell must be much lower than 1 µM, and may even be closer to 0.03 µM [60] (Fig. 4) . Inhibition of heme synthesis enhanced the nuclear accumulation of Bach1, whereas treating cells with hemin resulted in nuclear exclusion of Bach1. A region containing two of the heme-binding motifs is also critical for the heme-induced nuclear exclusion. This region functioned as a heme-regulated nuclear export signal that is dependent on the exporter Crm1 [61] . These findings indicate that the regulatory role for heme extends to protein sorting.
In yeast cells, it was shown that Hap1 activity is controlled in vivo by heme and not by its precursors, and that the intracellular signaling heme level, reflected as Hap1 activity, is closely correlated with oxygen concentration up to 1 µM [62] . Thus heme plays a central role in oxygen sensing and utilization in yeast cells.
Biological Effects of Heme Degradation Products
The three enzymatic products of heme oxygenase reaction, i.e., iron, biliverdin IXα and CO, can obviously be toxic if they are produced in an abnormally high concentration. Under such conditions, iron resulting from heme catabolism can be involved in reactive oxygen species generation, and CO might reach a toxic concentration. Bilirubin IXα, the reduced metabolite from biliverdin IXα, can also be toxic at concentrations above the saturation with serum albumin, and may influence lipid polarity and fluidity, protein order, and redox status [63, 64] . However, these three metabolites are not toxic at all in physiological concentrations in normal cells, and may also have important biological functions.
First of all, iron is an essential substrate for new hemoglobin synthesis. For example, mice deficient in heme oxygenase-1 develop iron deficiency anemia because of low serum iron levels [65] . Iron is also necessary for normal development, since a child with congenital heme oxygenase-1 deficiency was found, in addition to microcytic hypochromic anemia, to have severe growth retardation [49] . It is also well known that various organisms use heme oxygenase for iron acquisition for their cellular growth [66] .
Secondly, both biliverdin IXα and bilirubin IXα, as well as their glucuronides, have been shown to be potent antioxidants [67] . Conversely, low serum bilirubin levels have also been shown to be a risk factor for coronary artery disease [68] . In addition, bile pigments produced by heme oxygenase-1 induction was shown to display protective actions in vitro and in vivo [69] [70] [71] [72] .
Thirdly, CO formed from the cleavage of heme by heme oxygenase, which accounts for the majority of CO-formation in the body [73, 74] , has recently been shown to be as a second messenger in the central nervous system [75] , and also to suppress apoptosis of endothelial cells via the activation of p38 MAPK [76] . CO appears to be necessary for appropriate maintenance of enteric smooth muscle resting membrane potential, and exogenous CO restores inhibitory transmission in contracted muscle of heme oxygenase-2 −/− mice. These effects of CO also require soluble guanylate cyclase and the production of nitric oxide [77] . Heme oxygenase is also known to colocalize with soluble guanylate cyclase in regions of the human brain [78] . Since heme oxygenase-2, which is expressed throughout in the brain, is generally non-inducible [79, 80] , "free heme" concentration must be the rate-limiting factor of CO production in the brain.
Thus, in addition to the removal of the pro-oxidant heme by the oxidative metabolism, heme oxygenase-1 in turn produces a series of metabolites from heme, all of which can act as important members of the host defense system, and contribute to the suppression of oxidative tissue injuries. Repression of ALAS1 synthesis in liver takes place at "free heme" concentrations at 0.1-0.3 µM, leading to decreased heme synthesis. "Free heme" in normal reticulocytes was reported to be also 0.1 µM. "Free heme" would be degraded efficiently at concentrations greater than 0.4 or 1.0 µM since they are Km for heme oxygenase-2 and heme oxygenase-1, respectively. Exogenously added "free heme" concentration to cultured liver cells greater than 1 µM induces heme oxygenase-1 expression, making the metabolic heme balance more toward negative since heme synthesis is profoundly inhibited at such concentration. In fact, these effects of "free heme" must be occurring at much lower concentrations than the added concentration to cell culture, since the cell absorbs little heme. Virtually no "free heme" is expected in normal cells at concentrations at or greater than 1 µM. In an inherited heme oxygenase-1 deficiency, however, 50 µM "free heme" was found in the patient's plasma, which was clearly abnormal and was associated with various tissue damages due to ROS generation. The three products of heme oxygenase reaction, iron, biliverdin IXα and CO, contribute to cellular defense in various ways. While an excess iron can be toxic, the toxic effect of iron generated by heme oxygenase in the cell is largely contained by the induction of ferritin. Biliverdin IXα, its reduced product bilirubin IXα and their glucuronides are potent anti-oxidants. CO can suppress apoptosis of endothelial cells via the activation of p38 MAPK. Thus, the results of heme catabolism at high "free heme" concentrations are the generation of a series of protective molecules against oxidative damages.
The adaptive induction response of heme oxygenase-1 to various oxidative stimuli, including hemin, suggests an entirely new paradigm for heme oxygenase-1, and an induction response of heme oxygenase-1 should now be recognized as a major protective defense of inflammatory processes and oxidative tissue injuries.
The Role of Heme in O2 Sensing
Recently, significant progress has been made in the understanding of the mechanism behind O2 sensing by cells. Among several hypotheses proposed, heme proteins have been held as a key player in O2 sensing as they undergo allosteric modification in response to O2 binding, or release at different pO2 levels. In this model, hypoxia is detected by an allosteric shift in a heme-containing protein, which attains a "relaxed" configuration upon binding O2 at the heme site, whereas it takes a "tense" configuration in the absence of O2 [81, 82] . In support of this hypothesis, it is known that cobaltous chloride induces the erythropoietin gene expression presumably by maintaining a tense configuration of the heme protein sensor, thus mimicking hypoxia. In contrast, exogenous CO inhibits the hypoxic induction of the erythropoietin gene, by its binding at the heme site in the sensor, which presumably induces the relaxed configuration of the heme protein, thereby also mimics O2 action [81] .
At least four heme-containing O2 sensor proteins have been identified in prokaryotes. Namely, FixL in Rhizobium melioti, the sensor kinase in the FixL / FixJ two-component signal transduction system, regulates the expression of N2 fixation genes in response to O2. The kinase activity is repressed by O2 binding to the Per-ARNT-Sim motif, or PAS domain, and protects the N2-fixation system from oxidative damage [83] [84] [85] . The heme-binding PAS domain is also found in other O2 sensors, and proteins with heme-PAS domains occur in all biological organisms, including mammals. HemAT is the O2-sensing signal transduction protein that is responsible for aerotaxis control in archaea and bacteria. HemAT contains a myoglobin-like domain at the N-terminal region that is responsible for the O2 response [86] . Dos, the direct oxygen sensor protein, is the O2-regulated phosphodiesterase from Escherichia coli and is a redox-sensor that uses the heme-PAS domain to sense O2 and to regulate enzymatic catalysis [87] . AxPDEA1 is the O2-modulated phosphodiesterase A1 from Acetobacter xylinum and is a homolog of Escherichia coli Dos implicated in the allosteric activation of the bacterial cellulose synthase pathway. It also contains a heme-PAS domain, which is homologous to the heme-binding PAS domain of the FixL histidine kinases, and is regulated by reversible binding of O2 to the heme [88] .
In addition to O2 sensors, two heme-based CO sensor proteins that contain the heme-PAS domain have also been found in bacteria. In bacteria that utilize CO as a sole energy source for their growth, a heme-based CO-sensing homodimeric transcriptional activator CooA has been demonstrated [89] . CO binding to the heme-PAS domain of CooA renders this protein competent for the transcriptional activation. It is very interesting to note that neuronal PAS domain protein 2 (NPAS2) in mammalian cells is a transcriptional factor that is implicated in the regulation of the circadian rhythm, and contains a heme-PAS domain. NPAS2 binds DNA as an obligate dimeric partner of BMAL1, the brain and muscle aryl hydrocarbon receptor nuclear translocator-like protein 1. CO binding to the heme-PAS domain of NPAS2 inhibits the transcriptional activator activity induced by NADPH [90] . NPAS2 is expressed mainly in the forebrain of mammals, where the rhythmic Per2 gene [91] , as well as the neuronal nitric oxide synthase gene and the heme oxygenase-2 gene are also markedly expressed [92] . These findings suggest that CO may also regulate the expression of NPAS2-targeted genes through heme-based sensor mechanism [93] . In addition to O2 and CO, heme-based sensors are also involved in sensing NO, and to induce cellular adaptation to changes in its concentrations.
Alternative to the heme-sensor hypothesis, it has also been proposed that NADPH-oxidase may decrease its generation of reactive oxygen species during hypoxia in mammalian cells [94] . In the presence of O2, this enzyme alters the redox state of the cells by generating superoxide anions, while under hypoxic conditions, it decreases superoxide formation and results in a more reduced environment in the cell. In this manner, decreased levels of reactive oxygen species can signal hypoxia [95] .
Most recent data yet suggest another mechanism. Namely, mitochondria may function as O2 sensors by increasing their generation of reactive oxygen species during hypoxia [95] . Hypoxia inhibits the activity of the mitochondrial electron transport chain complex IV (cytochrome c oxidase), which leads to the release of electron and generation of superoxide. This concept is supported by the fact that Hep3B ρ 0 cells which are devoid of mitochondrial DNA do not generate reactive oxygen species during hypoxia and fail to upregulate the expression of hypoxia-inducible genes [95, 96] . Thus, hypoxia can activate transcription via a mitochondriadependent signaling process involving increased reactive oxygen species. It is interesting to note that oxygen sensing is dependent on mitochondrial reactive oxygen species, but independent of oxidative phosphorylation [97] .
Mitochondria-derived reactive oxygen species also contributes to the stabilization of hypoxia-inducible factor-1α (HIF-1α) [98] . HIF-1α is a transcription factor that plays a pivotal role in cellular adaptation to changes in oxygen availability [99] . It is clear now that O2 sensing is not restricted to specific cell types, but rather is found ubiquitously in a wide variety of tissues to cope with hypoxic stress and for subsequent survival and adaptation [100] . In the presence of oxygen, HIF is targeted for destruction by an E3 ubiquitin ligase containing the von HippelLindau tumor suppressor protein (pVHL) [101] [102] [103] . pVHL binding to HIF is dependent on the hydroxylation of a conserved proline residue that is dependent on the presence of molecular oxygen and a ferrous ion [104] . This finding would potentially account for the stabilization of HIF-1α under hypoxia, and the seemingly similar stimulating effects on HIF activity by iron chelators.
Circadian Rhythm of The Oxidative Stress and Heme Metabolism
Recent data suggest that there may be significant circadian rhythm in the oxidative stress as well as in heme metabolism. It has also been shown that melatonin abolishes the oxidative stress that is due to mitochondrial radical formation. Melatonin is not only a potent scavenger of several free radicals but also is an important molecule of intraorganismal circadian communication that contributes to rhythmic changes in gene expression. The circadian system and melatonin synthesis are altered when light is extended into the normal dark period, or when the dark period is interrupted by light [105] . Melatonin deficiency is related to suppressed immunocompetence, and at least in one animal model, melatonin supplementation increased life-span although several other studies have failed to show such an effect [106] . Rhythmic changes in the oxidative damage of protein and lipid molecules are also reported [107] . Rhythmic changes in metabolic rates and free radicals that depend on mitochondrial activities might thus be expected (Fig. 5) . The significance of circadian rhythmicity in diminishing oxidative stress is made clear by experiments with clock mutants of Drosophila. Namely, moderately enhanced protein damage is described for the arrhythmic and melatonin-null mutant per 0 of Drosophila, and even more elevated, periodic damage is found in the short-period mutant per s . Large increases in oxidative protein damage and tissue impairment are also observed in the Harderian gland of a short-period mutant tau of the Syrian hamster. The Harderian gland, a lipid-rich juxtaorbital organ, is particularly vulnerable to oxidative stress, since it is physiologically subjected to oxidative stress, due to free radicals generated by a large amount of porphyrins and their precursor, δ-aminolevulinic acid (ALA) [108, 109] . ALAinduced oxidation of guanine bases, lipid peroxidation, and alterations in membrane fluidity can be prevented by melatonin treatment [110] . The remarkably high level of ALAS1 expression in the Harderian gland is also unique in that ALAS1 in this organ is not inducible by treatment with 2-allyl-2-isopropylacetamide, a potent inducer of ALAS1 in the liver. ALAS1 level is not suppressed by hemin treatment that is known to exert a feedback regulation of heme biosynthesis in the liver [111] . The markedly elevated ALAS1 expression in the Harderian gland thus permits synthesis of an enormous amount of ALA and porphyrins. The porphyrinogenesis in the Harderian gland is also known to exhibit a marked sexual dimorphism, as females produce far more porphyrins than do males, while castration of males greatly increases porphyrin synthesis and promote cell death due to increased oxidative stress [112] . It should also be noted that there is a biphasic, high-amplitude rhythm of lipid peroxidation in the Harderian gland of the female Syrian hamster that are characterized by marked morning and evening peaks [113, 114] . In contrast to females, males have much lower porphyrin levels and lower amplitude of the lipid peroxidation rhythm and their cells are better protected from oxidant injuries [112] [113] [114] .
It has also been shown that light is essential for porphyrin synthesis in the liver [115] , as an intervention of a neuro- Fig. 5 . Circadian rhythm of the oxidative stress and heme metabolism. Although the relationship between circadian rhythm of the oxidative stress and heme metabolism is yet hypothetical, there is significant evidence that suggests circadian rhythm in the oxidative stress as well as in heme metabolism. For one, porphyrin synthesis is under the control of light exposure [115] , and increased levels of porphyrins would contribute to oxidant stress. For the other, melatonin synthesis is under circadian control. Melatonin reduces oxidative stress [166] and influences porphyrin biosynthesis [167] . Rhythmic changes in the oxidative damage of proteins and lipid molecules have also been directly demonstrated. The expression of ALAS1, the rate-limiting enzyme in heme biosynthesis, is also under the control of the PER gene, a member of the circadian core oscillator.
endocrine pathway involving retina, nerve pathways in the brain and the sympathetic chain, the pineal gland and the gonads, abolishes drug-induced porphyria in the rat [115] ( Fig. 5) . Free radicals and other oxidants such as singlet oxygen can be also induced by light. There is also a rhythm in susceptibility of the rat retina to intense green light, assessed by tissue damage, heme oxygenase-1 expression, and DNA fragmentation, and this rhythm is abolished by the synthetic antioxidant dimethylthiourea [116] . The lightdependent porphyrin synthesis is thus related to circadian control [117] (Fig. 5) . The light-induced oxidative changes may even influence global aspects of cell biology such as cell survival. For example, life extension by melatonin or pineal grafts has been reported [118, 119] , though it is not known whether such treatments influence heme biosynthesis and oxidant defense response. In humans, the amplitude of the melatonin circadian rhythm is postulated as a physiological feature of healthy longevity [106, 120, 121] . While the role of melatonin or pineal gland on heme synthesis, oxidative stress, or longevity, yet remains elusive, their inter-relationship certainly warrants exploration. Mice deficient in the per2 gene homolog, a member of the circadian core oscillator, are known to be cancer-prone [122, 123] , which might also relate to oxidative stress. These mice exhibit a short-period phenotype followed by a loss of circadian rhythmicity in constant darkness, and they are more susceptible to γ-irradiation than the wild-type animals. These findings may suggest defective cell cycle control, changes in myc expression, and Myc-dependent transcripts, as well as lower sensitivity to apoptotic signals. The role of Myc is complex, however, as it not only enhances oxidant formation related to cytochrome c release, but also regulates many other genes related to oxidant protection [124, 125] . It is also known that an antioxidant response element (ARE) as well as a Myc / Max heterodimer binding site is present in the promoter of the heme oxygenase-1 gene [124] . These findings may suggest that circadian core oscillator genes such as per2 should be expected to regulate many output functions, including the possibility of direct or indirect influences on genes of antioxidative protection.
As heme concentrations are determined by the level of ALAS1 expression that is now shown to be under the PER regulation [126] , heme concentrations may be part of an interface between the core clock mechanism and the cellular environment. As mPER1 mutants do not advance and mPer2 mutants do not delay the clock [91] , it is clear that both mPER1 and mPER2 are not only light-responsive components of the circadian oscillator but also essential for normal resetting of the circadian clock [91] . NPAS2, a basic helixloop-helix PAS domain transcription factor expressed in multiple regions of the vertebrate brain, can form a heterodimer with BMAL1 protein to produce an active transcription complex [127] . NPAS2-deficient mice exhibit deficits in the long-term memory arm of the cued and contextual fear task [127] . Thus NPAS2 may serve a dedicated regulatory role in the acquisition of specific types of memory [127] . Such findings indicate a direct influence of cellular redox balance, including oxidative stress and free heme levels, on the circadian clock [107] (Fig. 5) . In this respect, it is also important to note that genes encoding key enzymes in the heme biosynthetic pathway are under circadian control and are regulated by mPER1 and mPER2 in mice [126] .
These findings suggest that both circadian control of physiological processes and a possible regulatory role of free heme on these processes, possibly via PAS proteins that are heme binding, might be interconnected. Studies of clock-controlled genes may uncover a new pattern of gene expression that can be controlled by circadian changes in free heme concentrations in the cell, which may relate to a wider implication for temporal control of the biochemical and physiological processes of an organism.
Hypoxia and Heme Oxygenase-1 Induction
Hypoxia elicits a variety of adaptive responses at the tissue, at the cellular, as well as at the molecular level. A physiological response to hypoxia requires the existence of an O2 sensor coupled to signal transduction system, which in turn elicits the functional response. Recent evidence indicates that heme oxygenase-1 induction may be influenced by O2 concentrations as it takes place in response to hypoxia both in vitro in various cell types and in vivo in several tissues. For example, exposure of rat aortic vascular smooth muscle cells in vitro to 1% O2 results in the accumulation of heme oxygenase-1 mRNA, and exposure of rats in vivo to hypoxia (7% O2) increases the levels of heme oxygenase-1 mRNA in several tissues. This induction is dependent on gene transcription [128] . As such, heme oxygenase-1 may be involved in the adaptive response to changes in oxygen concentrations. In the lung, hypoxia causes increased vasoconstriction and vessel-wall remodeling [129] . Hypoxia transiently increases the transcriptional rate of the heme oxygenase-1 gene in the lung, resulting in increased production of CO, and bilirubin IXα (Fig. 6) . As CO has vasodilatory and antiinflammatory effects in the vasculature, and bilirubin is an antioxidant, both enzymatic metabolites by heme oxygenase reaction may be needed for cytoprotection. Hypoxia also induces a pronounced inflammation in the lung, while mice overexpessing heme oxygenase-1 by transgene approach are protected from the development of pulmonary inflammation induced by hypoxia [130] . Hypoxic induction of proinflammatory cytokines was also suppressed in transgenic mice overexpressing heme oxygenase-1 [130] .
A critical role of HIF-1α in heme oxygenase-1 induction during hypoxia has also been established by the findings that hypoxia significantly increases the transcriptional rate of the heme oxygenase-1 gene [131] , the rate of bilirubin formation and CO production (Fig. 6) , and cGMP content in pulmonary smooth muscle cells [132] , while hypoxiadependent heme oxygenase-1 expression was abolished in mutant cells lacking HIF-1α DNA-binding activity [128] . It is also known that mitochondrial reactive oxygen species are required for the hypoxic activation of proinflammatory genes such as NF-κB and TNF-α gene transcription [133] . Expression of endothelial heme oxygenase-1 appears to be, however, differentially regulated by hypoxia, depending on the vascular bed, or the degree of hypoxia [129] . For example, while heme oxygenase-1 mRNA levels are induced in aortic and pulmonary artery endothelial cells during hypoxia [134, 135] , they are suppressed in hypoxic human umbilical vein endothelial cells [136, 137] . Heme oxygenase-1 mRNA in the latter cells is, however, increased by cobalt chloride treatment that is known to mimic hypoxia. The different effect of hypoxia and cobaltous chloride on heme oxygenase-1 induction can be accounted for by the fact that hypoxia activates transcription via a mitochondriadependent signaling process involving increased reactive oxygen species (Fig. 6) , whereas cobaltous chloride activates transcription by stimulating reactive oxygen species generation via a mitochondria-independent mechanism [95, 98] . However, hypoxia also repressed heme oxygenase-1 mRNA expression in human coronary artery endothelial cells and astrocytes [137] , suggesting that heme oxygenase-1 mRNA expression may be markedly different depending on cell types. The increase in heme oxygenase-1 in smooth muscle cells is mediated by HIF-1 binding to the hypoxiaresponsive element at approximately −9 kb of the heme oxygenase-1 promoter [128] . It remains unclear, however, whether repression of heme oxygenase-1 expression may represent the adaptation to hypoxia or not in these cells. In hypoxic cells, there is a global reduction in protein synthesis that serves to conserve ATP by reducing the synthesis of all nonessential proteins [138] . Thus it is noteworthy that heme oxygenase-1 induction, similar to neuronal nitric oxide synthase induction [139] takes place against the background of a global reduction in protein synthesis in hypoxic cells, suggesting that induction of heme oxygenase-1 is an essential cellular function to cope with oxidative stress during hypoxia.
Exogenous CO is, however, known to inhibit hypoxic induction of certain HIF-1α-regulated genes such as erythropoietin [82] , VEGF [140] , ET-1 and PDGF-B genes [141] . Effect of hypoxia on heme oxygenase-1 induction does not seem to be long-lasting in that increased heme oxygenase-1 mRNA and enzymatically produced metabolite levels return close to baseline levels by 48 h [132] . The inhibitory effect of CO on heme oxygenase-1 expression may potentially be due to its inhibition of DNA-binding activity of HIF-1α, as it is known to suppress HIF-1 production at high CO concentrations (>80% CO) [142] , though it does not seem to influence HIF-1 production at low concentrations (5% CO). Thus, endogenous CO production by heme oxygenase following hypoxia may account for the transient negative feedback inhibition on heme oxygenase-1 gene expression [132] .
The Role of Heme Oxygenase-2 as An Oxygen Sensor
Heme oxygenase-2 is highly and constitutively expressed in neuronal and chemosensing tissues, including carotid body glomus cells [78, [143] [144] [145] and myenteric and submucosal neuronal cell bodies in jejunum [146] , whereas heme oxygenase-1 is not. Recent evidence suggests functional interaction between heme oxygenase-2 and largeconductance calcium-sensitive potassium (BK) channels in the glomus cells [147] . BK channels in vascular smooth muscle cells sense both changes in membrane potential and in intracellular calcium concentration. BK channels may serve as negative feedback regulation of vascular tone by linking membrane depolarization and local increases in intracellular calcium concentration, "calcium sparks", to repolarizing spontaneous transient outward K + currents. BK channels are composed of channel-forming BKα and auxiliary BKβ1 subunits. Knockdown of heme oxygenase-2 expression reduced BK channel activity, while CO rescued this loss of function [147] . Hypoxia inhibited BK channels that were dependent on heme oxygenase-2 stimulation. Carotid body also showed heme oxygenase-2 -dependent hypoxic BK channel inhibition, thus heme oxygense-2 can be considered as an oxygen sensor that controls channel activity during oxygen deprivation [147, 148] . CO also regulates the ion channel activity. Namely, CO activates large-conductance Ca 2+ -activated K + channels in newborn porcine carotid arteriole smooth muscle cells [149] . In this system, CO modifies the binding of ferrous heme, but not that of ferric heme, to the α subunit of the heme-binding domain of the channel α subunit C terminus, and on binding CO, heme switches from being a channel inhibitor to an activator [150] . These findings indicate the novel role of heme oxygenase-2 as an oxygen sensor, as well as a novel process by which gaseous messenger molecules such as O2 and CO regulate ion channel activity.
Implications of Heme Oxygenase-1 Induction
As discussed above, induction of heme oxygenase-1 in response to oxidative stresses in a variety of tissues and organs appears to be overwhelmingly cytoprotective, and can be considered as an essential component in the biological defense response. The critical requirement of heme oxygenase-1 under physiological as well as stressed conditions is best seen in the first case of human heme oxygenase-1 deficiency [49] and in mice lacking heme oxygenase-1 expression [151] as they exhibited marked susceptibility to oxidative tissue injuries in various organs. In addition, inhibition of HO activity by synthetic metalloporphyrins such as Sn-protoporphyrin IX, Sn-mesoporphyrin IX, or Zn-protoporphyrin IX, aggravated oxidant stress-induced tissue injuries [152] , while primed induction of heme oxygenase-1 by heme/ hemoglobin or heavy metals prior to the oxidant challenge, as well as heme oxygenase-1 gene transfer significantly protected tissues from the stressconditioned events [152] . Recent evidence also suggests that some of these cytoprotective effects by heme oxygenase-1 induction may be accounted for by the increased production of heme metabolites, namely bile pigments and CO. For example, targeted gene deletion of heme oxygenase-2 resulted in the loss of intestinal neurotransmission [153] ; CO protected against the development of experimental necrotizing enterocolitis [154] ; and heme oxygenase-2 protected against lipid peroxidation-mediated cell loss and impaired motor recovery after traumatic brain injury [155] ; and both CO and bilirubin, formed by activation of heme oxygenase-2, also protected neurons against oxidative stress injury [156] .
On the other hand, it has been long known that all heme metabolites can be vastly toxic if they are produced in excess. Thus there must be an appropriate range of heme oxygenase-1 expression which needs to be defined better for each tissue, organ, and toxic stimulus. To complicate the issue further, there have been reports on disparate effects of heme oxygenases on cytoprotection in some organs, e.g., brain. For example, while heme oxygenase-2 was neuroprotective in cerebral ischemia [157] , and deletion of the heme oxygenase-2 gene increased the vulnerability of astrocytes to hemin, the heme oxygenase-2 gene deletion also resulted in the attenuation of oxidative stress in neurons in mixed neuron / astrocyte cultures exposed to extracellular hemin [158] . Some investigators also reported that heme oxygenase inhibitors such as Sn-mesoporphyrin are protective in models of CNS hemorrhage [159] [160] [161] . In these models, heme oxygenase inhibitors reduced intracerebral mass by decreasing both hematoma and edema volumes. The mechanism of action of heme oxygenase inhibitors in these models is presently unknown as their effects appear unrelated to ferritin iron release, antioxidant activity or initial clot formation [158] . CO can also be toxic depending on tissues and doses. For example, heme oxgenase-1 gene transfer in neonatal mouse lungs exacerbated lung injury as measured by protein carbonyls and 8-isoportanes [162] . Relatively low levels of CO exposure at 10-110 ppm induced NO-mediated endothelial cell apoptosis [163] , while high levels of CO resulted in pronounced perivascular injury in the brain of rats due to increased peroxynitrite and NO levels [164] . These findings suggest that there may be potential toxic consequences by CO and as well as a crosstalk between NO and CO that may further modulate the regulation of heme oxygenase-1 activation. Better understanding on potential interactions among different networks clearly needs further investigations.
Although heme oxygenase-1 induction may be either cytoprotective, or cytotoxic depending on the condition, transcriptional activation of heme oxygenase-1 gene expression is clearly the hallmark of tissue response to oxidative stresses. Thus heme oxygenase-1 and its expression can be considered as an appropriate target of treatment modality in oxidative tissue injuries including sepsis, inflammation, cerebral hemorrhage, allergy, and organ transplantation, etc.
Concluding Remarks
Biological implications of free heme and heme metabolites are reviewed. Free heme exerts various regulatory functions, including repression of ALAS1 synthesis, inhibition of Bach1 DNA binding activity, and activation of the heme oxygenase-1 gene, etc. In addition to its key role in heme catabolism, heme oxygenase-1 shows immediate gene activation in response to various oxidative stimuli, suggesting that it may play an important role in the adaptive protection. Heme oxygenase-1 is also potently induced in response to hypoxia in many tissues, while heme oxygenase-2 has now been shown to be an oxygen sensor. Both CO and biliverdin IXα, enzymatic degradation products of free heme by heme oxygenases, are recognized as important molecules in the protective responses against oxidative tissue injuries. Accumulating evidence also suggests that there may be an oscillatory control of both heme synthesis and oxidative stress, depending on the light-dark period. These findings suggest that heme metabolites may play significant roles in tissue protection, oxygen sensing, and circadian control in oxidative tissue injury.
